title: Human papillomavirus infection and the multistage carcinogenesis of cervical cancer.
abstract: This short review outlines our understanding of cervical cancer precursors, concentrating on the central etiologic role of persistent human papillomavirus infection. The stages of cervical carcinogenesis are better understood than for most other major cancers, providing a successful cancer etiology and prevention model.
authors.affiliation: Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd., Room 7012, Rockville, MD 20852, USA. schiffmm@mail.nih.gov
authors.forename: Mark
authors.initials: M
authors.lastname: Schiffman
authors.forename: Nicolas
authors.initials: N
authors.lastname: Wentzensen
mesh_terms: D002471:Cell Transformation, Neoplastic / Q000473:pathology*; D018450:Disease Progression; D005260:Female; D006801:Humans; D027383:Papillomaviridae / Q000472:pathogenicity*; D030361:Papillomavirus Infections / Q000473:pathology / Q000821:virology*; D012307:Risk Factors; D002583:Uterine Cervical Neoplasms / Q000209:etiology* / Q000473:pathology
references.citation: Cancer Detect Prev. 1990;14(4):461-4
references.pmid: 2171769
references.citation: Future Microbiol. 2011 Sep;6(9):1083-98
references.pmid: 21958146
references.citation: J Natl Cancer Inst. 2012 Nov 21;104(22):1738-49
references.pmid: 23093560
references.citation: Int J Cancer. 2011 Mar 1;128(5):1192-203
references.pmid: 20853317
references.citation: Cancer Res. 2008 May 1;68(9):3532-9
references.pmid: 18451182
references.citation: Dis Markers. 2007;23(4):315-30
references.pmid: 17627065
references.citation: Int J Cancer. 2013 Sep 15;133(6):1271-85
references.pmid: 22961444
references.citation: Trends Endocrinol Metab. 2010 Aug;21(8):504-11
references.pmid: 20456973
references.citation: J Natl Cancer Inst. 2011 Mar 2;103(5):368-83
references.pmid: 21282563
references.citation: J Natl Cancer Inst. 2010 Oct 6;102(19):1478-88
references.pmid: 20841605
references.citation: J Natl Cancer Inst. 2008 Apr 2;100(7):513-7
references.pmid: 18364507
references.citation: Lancet Oncol. 2008 May;9(5):404-6
references.pmid: 18452848
references.citation: Lancet Oncol. 2011 Jul;12(7):663-72
references.pmid: 21684207
references.citation: Lancet. 2003 Apr 5;361(9364):1159-67
references.pmid: 12686037
references.citation: Lancet. 2009 Jul 25;374(9686):301-14
references.pmid: 19586656
references.citation: J Natl Cancer Inst. 2012 Apr 4;104(7):556-65
references.pmid: 22448030
references.citation: Lancet Oncol. 2008 May;9(5):425-34
references.pmid: 18407790
references.citation: Int J Cancer. 2012 Apr 15;130(8):1879-87
references.pmid: 21607948
references.citation: J Low Genit Tract Dis. 2012 Jul;16(3):205-42
references.pmid: 22820980
references.citation: Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):10516-21
references.pmid: 22689991
references.citation: J Clin Pathol. 2002 Apr;55(4):244-65
references.pmid: 11919208
references.citation: Cancer Epidemiol Biomarkers Prev. 2012 Dec;21(12):2125-37
references.pmid: 23035178
references.citation: CA Cancer J Clin. 2012 May-Jun;62(3):147-72
references.pmid: 22422631
references.citation: J Natl Cancer Inst. 2005 Jul 20;97(14):1072-9
references.pmid: 16030305
references.citation: Lancet. 2007 Sep 8;370(9590):890-907
references.pmid: 17826171
references.citation: Cancer. 2004 Mar 1;100(5):1035-44
references.pmid: 14983500
references.citation: Nat Rev Microbiol. 2012 Oct;10(10):681-92
references.pmid: 22961341
references.citation: N Engl J Med. 1998 Feb 12;338(7):423-8
references.pmid: 9459645
references.citation: Br J Cancer. 1989 Jul;60(1):132-41
references.pmid: 2803910
references.citation: J Natl Cancer Inst. 2006 Mar 1;98(5):303-15
references.pmid: 16507827
references.citation: Virology. 2005 Jun 20;337(1):76-84
references.pmid: 15914222
references.citation: Am J Clin Pathol. 2007 May;127(5):805-15
references.pmid: 17439841
references.citation: Int J Cancer. 2006 Mar 15;118(6):1481-95
references.pmid: 16206285
references.citation: JAMA. 2001 Mar 21;285(11):1500-5
references.pmid: 11255427
references.citation: J Adolesc Health. 2008 Oct;43(4 Suppl):S5-25, S25.e1-41
references.pmid: 18809145
references.citation: Lancet Oncol. 2005 Apr;6(4):204
references.pmid: 15830458
references.citation: J Natl Cancer Inst. 2012 Nov 21;104(22):1712-23
references.pmid: 23104323
references.citation: Lancet Oncol. 2008 Oct;9(10):929-36
references.pmid: 18805733
references.citation: Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):113-20
references.pmid: 19124488
references.citation: Nat Rev Cancer. 2002 May;2(5):342-50
references.pmid: 12044010
references.citation: Cancer Res. 2010 Apr 15;70(8):3159-69
references.pmid: 20354192
references.citation: Proc Natl Cancer Conf. 1972;7:219-22
references.pmid: 4764902
references.citation: Vaccine. 2012 Nov 20;30 Suppl 5:F88-99
references.pmid: 23199969
references.citation: JAMA. 2007 Aug 15;298(7):743-53
references.pmid: 17699008
references.citation: Int J Cancer. 2009 Nov 1;125(9):2151-8
references.pmid: 19585494
references.citation: JAMA. 2002 Apr 24;287(16):2114-9
references.pmid: 11966386
references.citation: Obstet Gynecol. 2009 Jan;113(1):18-25
references.pmid: 19104355
references.citation: Arch Pathol Lab Med. 2004 Nov;128(11):1224-9
references.pmid: 15504056
references.citation: Gynecol Oncol. 2013 Feb;128(2):265-70
references.pmid: 23146688
references.citation: Lancet. 2009 Jun 6;373(9679):1949-57
references.pmid: 19493565